Business Description
RUA Life Sciences PLC
ISIN : GB0033360586
Description
RUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's principal activities comprise exploiting the value of its IP and know-how, medical device contract manufacturing, and development of cardiovascular devices. Its business segments are Royalty and License Income (Biomaterials), Contract Manufacture, Product Development (Vascular), and Product Innovation (Structural Heart). It derives the majority of its revenue from the Contract Manufacture segment. Geographically, it derives its major revenue from the USA and has a presence in Europe and the Rest of the world.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.11 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | -0.21 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -1 | |||||
| Beneish M-Score | -3.3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 43.7 | |||||
| 3-Year EBITDA Growth Rate | -22.4 | |||||
| 3-Year EPS without NRI Growth Rate | -19.3 | |||||
| 3-Year FCF Growth Rate | -33.9 | |||||
| 3-Year Book Growth Rate | 11.1 | |||||
| Future 3-5Y Total Revenue Growth Rate | 25.43 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.56 | |||||
| 9-Day RSI | 43.03 | |||||
| 14-Day RSI | 46.14 | |||||
| 6-1 Month Momentum % | -41.94 | |||||
| 12-1 Month Momentum % | -85 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.67 | |||||
| Quick Ratio | 2.4 | |||||
| Cash Ratio | 0.95 | |||||
| Days Inventory | 103.98 | |||||
| Days Sales Outstanding | 62.1 | |||||
| Days Payable | 225.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.5 | |||||
| Shareholder Yield % | -0.89 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 81.97 | |||||
| Operating Margin % | -135.63 | |||||
| Net Margin % | -100.05 | |||||
| FCF Margin % | -105.19 | |||||
| ROE % | -40.35 | |||||
| ROA % | -32.97 | |||||
| ROIC % | -46.59 | |||||
| ROC (Joel Greenblatt) % | -90.21 | |||||
| ROCE % | -48.93 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.31 | |||||
| PB Ratio | 0.65 | |||||
| Price-to-Tangible-Book | 0.73 | |||||
| EV-to-EBIT | -2.48 | |||||
| EV-to-Forward-EBIT | -5.7 | |||||
| EV-to-EBITDA | -2.9 | |||||
| EV-to-Forward-EBITDA | -7.41 | |||||
| EV-to-Revenue | 3.37 | |||||
| EV-to-Forward-Revenue | 1.92 | |||||
| EV-to-FCF | -3.45 | |||||
| Price-to-Median-PS-Value | 0.16 | |||||
| Price-to-Net-Current-Asset-Value | 4 | |||||
| Earnings Yield (Greenblatt) % | -40.36 | |||||
| FCF Yield % | -30.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
RUA Life Sciences PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2.14 | ||
| EPS (TTM) (€) | -0.097 | ||
| Beta | -0.18 | ||
| Volatility % | 49.71 | ||
| 14-Day RSI | 46.14 | ||
| 14-Day ATR (€) | 0.022936 | ||
| 20-Day SMA (€) | 0.0916 | ||
| 12-1 Month Momentum % | -85 | ||
| 52-Week Range (€) | 0.0625 - 0.488 | ||
| Shares Outstanding (Mil) | 62.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
RUA Life Sciences PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
RUA Life Sciences PLC Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
RUA Life Sciences PLC Frequently Asked Questions
What is RUA Life Sciences PLC(FRA:AOHA)'s stock price today?
The current price of FRA:AOHA is €0.08. The 52 week high of FRA:AOHA is €0.49 and 52 week low is €0.06.
When is next earnings date of RUA Life Sciences PLC(FRA:AOHA)?
The next earnings date of RUA Life Sciences PLC(FRA:AOHA) is 2024-07-26 Est..
Does RUA Life Sciences PLC(FRA:AOHA) pay dividends? If so, how much?
RUA Life Sciences PLC(FRA:AOHA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers